Pillstats
Rx only · Tablet, Extended Release · Oral

Lamotrigine

Lamotrigine

7 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US30 NDCs
7 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCN03AX09
RxCUI (US)28439
US makers7 labelers
Packages64
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 21 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.239$0.477$0.716$0.954Dec 2025Apr 2026Jul 2026
$0.712
Latest avg · Jul 22, 2026
-14%
Since Dec 17, 2025
7
Active US suppliers
50%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

28K56K84K112K2025 Q12025 Q22025 Q32025 Q42026 Q1
95K
Rx · 2026 Q1
4.5M
Units dispensed
+19%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it7 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Zydus Pharmaceuticals USA Inc.unknown18SUPPLYING
Dr.Reddy's laboratories Limitedunknown14SUPPLYING
Alembic Pharmaceuticals Limitedunknown12SUPPLYING
Torrent Pharmaceuticals Limitedunknown9SUPPLYING
NorthStar Rx LLCunknown6SUPPLYING
Proficient Rx LPunknown3SUPPLYING
REMEDYREPACK INC.repackager2SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Sep 11, 2018
    RECALLRecall (Class II): Lamotrigine Extended-Release Tablets, USP, 200 mg, 30 tablets per bottle, Rx Only, Manufactured in INDIA, For: TORRENT …

    Failed Dissolution Specifications: Out of Specification for Dissolution test (Buffer Stage) at the 5-hour time point during stability testing. — Recalling firm: Torrent Pharma Inc. — Nationwide USA